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CONTROL OF END-TIDAL HALOTHANE CONCENTRATION
Part B: Verification in Dogs
A. M. ZBINDEN, F. FREI, D. R. WESTENSKOW AND D. A. THOMSON
Currently, volatile anaesthetic agents are adminis-
tered according to their clinical effects as judged
by changes in haemodynamic, respiratory or
cerebral indices. Dosing is generally based on
empiricism, which may work well in the hands of
the experienced anaesthetist, while the trainee will
encounter difficulties. Theoretically, knowledge of
the expired concentration should permit pre-
diction of the patient's reaction to surgical
stimulation. Eger, Saidman and Brandstater
(1965) developed the concept of minimum alveolar
concentration (MAC) and De Jong and Eger
(1975) quantitatively established the relationship
between the log of the end-tidal concentration to
the probit of the motor response. Roizen,
Horrigan and Frazer (1981) established a similar
correlation between the end-tidal concentration
and the baro-adrenergic reaction of the patient.
Further correlations have been established be-
tween end-tidal and cerebral (EEG) depression
(Tinker, Sharbrough and Michenfelder, 1977),
and readiness for intubation (Yakaitis, Blitt and
Anguilo, 1977). Thus it appears that volatile
agents should be delivered so as to achieve a
precise end-tidal concentration.
The aim of this study was to test a new
anaesthetic breathing system which controls
precisely the end-tidal concentration. Arterial,
cerebral venous and mixed venous concentrations
were measured during the uptake of a volatile
anaesthetic. The results were compared with
mathematical models to predict brain and end-tidal
concentrations.
SUMMARY
Conventional anaesthetic techniques do not
allow for the automatic control of end-tidal
halothane concentration and. therefore, brain
concentration cannot be predicted. In this study,
eight dogs were ventilated with halothane in
oxygen using a new closed-loop anaesthetic
breathing system which provided a constant
end-tidal concentration. During the first 60 min
the end-tidal concentration was maintained at
0.87 vo/% (1 MAC). Then followed 60 min of
halothane wash-out and a further 120-min
period of halothane at 1.74 vo/% (2 MAC).
Halothane concentrations were measured in the
inspired and expired air, and in the arterial,
cerebral venous and mixed venous blood.
Haemodynamic and respiratory variables were
measured. The system reached 95% of the target
end-tidal concentration within 6 min without
over-shooting. After 2 h of wash-in, significant
gradients still persisted between end-tidal, arterial
and cerebral venous blood concentrations.
Measured uptake differed from theoretically
calculated uptake by 18.3-57.6%, depending on
the model used. Measured arterial and cerebral
venous concentrations differed from theoretically
calculated values by 7% and 17.5 %, respectively.
It was shown that the required end-tidal
concentrations can be obtained rapidly and
accurately, and that brain tissue concentrations
can be predicted within certain limits.
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MATERIALS AND METHODS
The closed-loop breathing system with feedback
control of the delivery of the anaesthetic is
described in the preceding paper (Westenskow et
al., 1986). In short, the system includes a 2-litre
water-sealed bellow, a circulating pump and a
soda-lime canister. Feedback controllers maintain
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end-tidal halothane concentration and system
volume at the desired level by regulating halothane
and oxygen inflow to the system. As leakage from
the system is negligible, oxygen and halothane
uptake by the subject equal the oxygen and
halothane supplied to the system.
Eight mongrel dogs (31-46 kg) were premedi-
cated with fentanyl 40 ug kg"1 and droperidol
2 mg kg"1 i.m. 1 h before instrumentation. Anaes-
thesia was induced with pentobarbitone
12 mg kg"1 i.v. and the trachea intubated. The
dogs were then placed on the operating table in the
supine position and the lungs ventilated with
100% oxygen at 12 b.p.m. with a tidal volume
sufficient to keep the arterial carbon dioxide at
5.0 kPa (38 mm Hg). To provide basal anaesthesia
during the surgical preparation and subsequent
experimental period, a bolus of droperidol 30 mg
and fentanyl 600 ug was given followed by a
continuous infusion of fentanyl 15 ug kg"1 h"1 and
pancuronium 60 ug kg"1 h"1. Sodium chloride
0.9% was infused at 2 ml kg"1 h"1 and temperature
was maintained at 37 °C. Haemodynamic moni-
toring consisted of ECG, arterial, central venous,
pulmonary artery and pulmonary capillary wedge
pressures via a catheter in the femoral artery, and
a thermistor-tipped flow-directed catheter inserted
via the internal jugular vein. Cardiac output was
measured in triplicate using an Edwards 520A
cardiac output computer with 5 ml iced injectate.
The halothane concentrations in arterial, cerebral
venous and mixed venous samples were determined
using a head space gas chromatography method
(Zbinden et al., 1985). The blood/gas partition
coefficient was measured in each dog. The
retroglenoid vein was isolated and all branches
ligated except that from the brain. A 1-mm
diameter Teflon catheter was advanced so that the
catheter tip was located intracranially.
Fifteen minutes after completion of the surgical
preparation, a complete set of measurements was
obtained to establish baseline values: arterial
pressure, heart rate, cardiac output, pulmonary
capillary wedge pressure, oxygen uptake, and
inspired, end-tidal, arterial, cerebral venous and
mixed venous halothane concentrations. Halothane
was then given to a feedback controlled end-tidal
concentration of 0.87 vol% (1 MAC for dogs
(Steffey and Howland, 1977)). Measurements
were repeated 1, 2,3, 6,9, 20, 40 and 57 min after
starting the halothane. After 60 min, halothane
was removed by introducing a 1.0-litre activated
charcoal absorber to the breathing system.
Wash-out continued for 60 min. During this
period, the same indices were measured at 61, 62,
63,66,69,80,100 and 117 min. Then the charcoal
filter was removed, and in the next 2-h period the
end-tidal concentration of halothane was increased
to, and maintained at, 1.74 vol% (2 MAC).
Measurements were taken 121,122,123,126,129,
140, 160, 180, 200 and 220 min after starting the
halothane.
Inspired, end-tidal, arterial, cerebral venous
and mixed venous concentrations were compared
with those predicted by the kinetic model of Zwart,
Smith and Beneken (1972), scaling the tissue
volumes, blood volumes and functional residual
capacity by 35.2/75.0 to correct approximately for
weight differences between the original model (in
man) and the mean weight of the dogs. The
average halothane uptake measured in this study
formed the input to the model. We used a
blood/gas partition coefficient of 3.41, a mean
arterial pressure of 88 mm Hg, a barometric
pressure of 740 mm Hg, a breathing system
volume of 2.5 litre, an initial cardiac output of
2.4 litre min"1, an alveolar ventilation of
1.4 litre min"1, and a physiological deadspace of
30 % of alveolar ventilation.
Halothane uptake was also compared with the
uptake model of Lowe and Ernst (1981). The
following symbols are used:
t = time in minutes after start of wash-in
Q, = measured cardiac output (dl min"1)
Ca = measured arterial blood concentration
X = measured blood/gas partition coefficient
W = measured body weight (kg)
Vot = measured oxygen uptake (ml min"1)
Fhal = calculated uptake of halothane (ml of
liquid min"1)
/240 = used to convert ml of vapour into ml of
liquid.
Three methods were used to calculate uptake. In
Method A the following equation was used:
PTial = C>-Ca-r-«-Y240. ( 0
This method used both the measured cardiac
output ((^) and the measured arterial blood
concentration (Ca). In Method B the following
equation was used:
This method used body weight to predict cardiac
output (Brody, 1945), a mean alveolar concen-
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FIG. 1. Measured concentrations (means of eight dogs) of various body compartments are compared
during the 1 MAC period, the wash-out period and the 2 MAC period. Blood concentrations were
divided by the blood/gas partition coefficient for comparison with the concentration of the gas phase.
tration of 0.87 vol % and a blood/gas partition
coefficient of 3.4 to predict arterial concentration.
Method C was obtained using the following
equation:
Fhal= • 0.87- 3.4 •r°-8/240. (3)
This method used measured oxygen uptake to
predict cardiac output, a mean alveolar concentra-
tion of 0.87 vol % and blood/gas partition coeffi-
cient of 3.4 to predict arterial concentration.
RESULTS
Figure 1 shows the halothane concentrations in the
inspired and end-tidal gas, and in the arterial,
cerebral venous and mixed venous blood during
wash-in with 0.87 vol % (1 MAC) end-tidal
concentration, during wash-out and during
wash-in at 2 MAC end-tidal concentration.
Within 6min, 96% of the desired end-tidal
halothane concentration was reached during the 1
MAC induction and 95 % within the first 6 min of
2 MAC induction. After 20 min, the coefficient of
variation of the end-tidal concentration was 6.3 %
at 1 MAC and 3.8% at 2 MAC. The end-tidal
concentration increased from 1.65 vol % at
126 min to 1.79 vol% at 237 min as the result of
an offset error in the feedback system (Westenskow
et al., 1986). The end-tidal concentration averaged
74 % of the inspired concentration after 57 min of
wash-in at 1 MAC and 77 % after 60 min of wash-in
at 2 MAC. After the first 57 min of wash-in at 1
MAC, the arterial concentration was 78%, the
cerebral venous was 64% and the mixed venous
56% of the end-tidal concentration. After 60
(120) min at 2 MAC, the arterial concentration
was 77 % (77 %), the cerebral venous 65 % (70 %)
and the mixed venous was 57% (64%) of the
end-tidal concentration. The correlation coefficient
between (CAhal - Ca^,) and (Cihal - CAhal) was
0.64 with a slope of 0.165 during the 1 MAC
period (where CAhal = end-tidal concentration,
Cahal = arterial concentration, Cihal = inhaled
concentration). After inserting the charcoal
absorber to the closed-loop, the inspired concen-
tration decreased to 0.08 ±0.01 vol% within
1 min. The end-tidal concentration decreased
exponentially to 0.15 ±0.05 vol % after 57 min.
The end-tidal, arterial, cerebral venous and mixed
venous concentrations decreased concomitantly.
Figure 2 compares measured concentrations in
five compartments with the simulated data from
the model of Zwart, Smith and Beneken (1972).
The fit between measured and simulated end-tidal
566 BRITISH JOURNAL OF ANAESTHESIA
simulation
) measured—— |
30
Time (min)
FIG. 2. Measured concentrations (means of eight dogs) of various body compartments during the 1 MAC
period in comparison to theoretical values according to the model of Zwart, Smith and Beneken
(1972).
concentration was good. The fit for the arterial,
cerebral venous and mixed venous blood concentra-
tions was not as good. During the first minutes, the
measured concentrations increased more rapidly
than the simulated.
The average rate of halothane uptake during the
1 MAC period was:
V (ml liquid min"1 kg"1)
For the 2 MAC period:
V (ml liquid min"1 kg"1)
= 25.4e"°"' + 3.0e-*-0331 + 1.3.
Figure 3 compares the 1 MAC measured uptake
curve with the three curves (A, B, C) calculated
from equations (1), (2) and (3), which are based on
Lowe and Ernst (1981).
Table I compares the areas under the experi-
mental to the areas under the calculated values for
concentration and uptake. The best fit between
measured and predicted uptake was obtained
when all measurable values were used (fig. 3,
Curve A). The total area under the curves was
almost identical, although the shapes of the curves
were different, with the theoretical curve increasing
— simulated
- - measured
30
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FIG. 3. Measured whole body halothane uptake and simulated
uptake using the Lowe and Ernst (1981) model. In the Lowe
model A measured cardiac output and measured arterial
halothane concentration were used. In Lowe model B, body
weight was used to predict cardiac output at a mean alveolar
halothane concentration of 0.87 vol% and a blood/gas
partition coefficient of 3.4 was used. Model C is the same as
model B, but measured oxygen consumption was used to
predict cardiac output.
first before declining exponentially. Using body
weight to predict cardiac output and a mean
alveolar concentration and blood/gas partition
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TABLE I. Comparison between measured and calculated values. Zwart'smodel is used to-predict concentration
in various compartments. Lowe's model is used to predict the whole-body uptake. In the Lowe model A,
measured cardiac output and measured arterial halothane concentration were used. In Lowe model B, body
weight was used to predict cardiac output at a mean alveolar halothane concentration of 0.87 vol% and a
blood/gas partition coefficient of 3.4 was used. Model C was the same as model B, but measured oxygen
consumption was used to predict cardiac output. The areas between the curves (ABC) divided by the area under
the calculated curve (A UCa^ are given as well as the area under the measured curve (A UCmlnt) divided
by the area under the calculated curve
ABC )
Inspired concentration
End-tidal concentration
Arterial concentration
Cerebral concentration
Venous concentration
Uptake according to Lowe A
Uptake according to Lowe B
Uptake according to Lowe C
10.6
5.3
7.0
17.5
14.9
18.3
24.8
57.6
91.1
108.8
108.5
103.4
100.0
99.1
80.1
63.5
TABLE II. Haemodynamic variables and oxygen uptake, t = Time (mm) after start of wash-in. All values
are expressed as mean ± standard deviation
Control
1 MAC (r = 57)
Washout (t = 117)
2 MAC (r = 180)
2 MAC (t = 240)
Arterial pressure
(mmHg)
88.35 ±35
74±19
96 ±17
52±16
50±16
Heart rate
(beat min"1)
116±21
102 ±24
125±26
115±21
114±13
(litre min ' kg >)
0.113 ±0.032
0.088 ±0.021
0.129 ±0.030
0.075 ±0.020
0.076 ±0.023
(ml min"1 kg"1)
5.70±1.05
5.07 ±0.88
4.99±1.77
4.75 ±0.94
4.78 ±0.87
coefficient, resulted in a considerable overestimate
of the uptake (fig. 3, Curve B). Using measured
oxygen uptake resulted in an even greater
overestimate (fig. 3, Curve C).
Haemodynamic indices, halothane uptake and
oxygen uptake are displayed in table II. Arterial
pressure, heart rate, cardiac output and oxygen
uptake at each period were compared with the
control value at the beginning of the experiment.
The haemodynamic depression was no more
severe immediately after induction (6 min) at both
1 MAC and 2 MAC than at the end of the period,
despite high inspiratory concentrations. Thus
haemodynamic indices remained stable after the
beginning of the wash-in period. The cumulative
halothane uptake averaged 3.8 ± 0.5 ml during the
1 MAC period and 9.3 ±0.9 ml of liquid halothane
during the 2 MAC period (this includes the system
uptake of approximately 0.48 ml). The average
halothane blood-gas solubility was 3.41 ±0.11.
Throughout all procedures, PaCOt and Pao,
averaged 5.6 ±0.1 kPa (42 ±0.9 mmHg) and
55.2 ±2 kPa (414± 14 mm Hg), respectively. The
end-tidal PCOt averaged 35 ±0.8 mmHg, the
temperature 37.1 ±0.8 °C.
DISCUSSION
This study describes the successful application of
an automatic system which controlled the end-tidal
halothane concentration. It was shown that a
target end-tidal concentration could be obtained
rapidly without overshoot. Furthermore, stable
anaesthesia was obtained for several hours as
judged by the absence of significant haemodynamic
variability. Future clinical application may show
that the controller is not optimized for patients:
even if body weight or more sophisticated
measurements (body surface, etc.) are used to
preset the gains, large inter-individual and
intra-individual variability in the uptake character-
istics may make it necessary to use a self-adaptive
controller, that is, one which tunes itself according
to the patient's response.
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Tatnall, Morris and West (1981) used the
difference between the measured inspiratory and
expiratory concentration to set the constants of
their feedback system. In a study with 80 patients,
Morris, Tatnall and Montgomery (1983) evaluated
the system and found it able to accommodate
individual patient response, to change the alveolar
concentration of the anaesthetic in 1-2 min and to
be resistant to measurement disturbances (dia-
thermy). The controller needed approximately
10 min for initial identification. Thus it was not
self-adaptive during the critical period of induction
of anaesthesia, nor did it change its characteristics
in subsequent periods. Furthermore, it was used
in a completely open system. Recent work by
Smith and colleagues (1984) has shown that
feedback control systems are capable of assuming
certain of the anaesthetist's tasks. It was also
shown that control systems often performed
better than the experienced anaesthetist.
Successful end-tidal control does not necessarily
result in precise control of arterial or brain
concentrations. During the time of observation
(2 h) we observed persistent end-tidal to arterial,
and arterial to cerebral venous, gradients. These
gradients diminished very slowly over time. To
predict the concentrations in gas, tissue and
blood compartments, theoretical models for the
uptake and distribution of volatile anaesthetics
have been developed. Most of these models are
based on the work of Kety (1951) on the uptake
of inert gases. Mapleson (1962, 1963) described a
kinetic model for halothane which he based on data
for tissue volumes, blood flows and tissue/gas
partition coefficients obtained from several investi-
gators. He could only partially verify this model
experimentally and found it limited by the
assumption of a uniform blood flow per unit tissue
volume. In 1973, Mapleson evaluated a new
model, which considered circulation time as well.
This resulted in more accurate concentration
curves for the first minutes of induction of
anaesthesia. The more recent models (Ashman,
Blesser and Epstein, 1970; Zwart, Smith and
Beneken, 1972; Fukui and Smith, 1981a, b)
consider the impact of the anaesthetic concentra-
tion on haemodynamics and respiration. Fukui
and Smith's (1981a) 18-compartment model, the
most sophisticated, considers respiration as cyclic,
and incorporates a loop between baroreceptors and
heart rate which is affected by the halothane
concentration. This model has not been tested
BRITISH JOURNAL OF ANAESTHESIA
experimentally and, furthermore, does not include
the anaesthetic delivery system.
Uptake models usually make the following
unverified assumptions:
(1) No metabolism occurs. However, up to 20%
of halothane taken up by the body seems to be
metabolized (Rehder et al., 1967; Sawyer et al.,
1971).
(2) No diffusion exists between tissues or
through the skin. The contrary was first suggested
by Perl and co-workers (1965) and later verified for
the skin (Stoelting and Eger, 1969a) and for the
tissues (kidney and perirenal fat tissue) (Allott,
Steward and Mapleson, 1976). Allott, Steward
and Mapleson (1976) found that the area under the
calculated arterial concentration curve was 7.4%
higher than the area under the measured arterial
curve, confirming an earlier and similar study by
Cowles, Borgstedt and Gillies (1972).
(3) Halothane concentration does not affect
organ function. Either heart or brain tissue
anaesthetic concentration controls the contractility
of the myocardium. Other factors also influence
organ function: Munson and Bowers (1967) have
shown theoretically two antagonistic effects of
hyperventilation on the rate of cerebral anaesthetic
uptake—hyperventilation increased the increase
in alveolar concentration while hypocarbia de-
creased cerebral perfusion and uptake. Analogous
results have been found during recovery (Stoelting
and Eger, 1969b).
(4) Ventilation and circulation are continuous
cyclic processes.
(5) Gas can diffuse freely through the surface of
the walls of the capillaries, thus the concentration
of the agent in the venous blood equals the
concentration dissolved in the tissue.
(6) The concentration of the agent in the
arterial blood equals alveolar concentration.
(7) The Ostwald tissue/gas and blood/gas
partition coefficients are independent of concentra-
tion and remain constant.
(8) The circulation time from lungs to tissues is
insignificant.
(9) Blood flow to the compartments is constant
and not dependent on the anaesthetic concen-
tration.
(10) Data for organ weights and blood flows are
well defined. However, these vary considerably
from author to author (Cowles, Bergstedt and
Gillies, 1971; Smith and Smith, 1972; Mapleson,
1973).
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(11) The anaesthetic system delivers well-
defined concentrations. In none of the models is
the anaesthetic breathing system included. In
semiclosed systems inspired or end-tidal concen-
trations are not well denned.
In this study, the Zwart, Smith and Beneken
model (1972) was used. It is not as complicated as
the more recent Fukui and Smith model (1981a)
and yet it considers the impact of anaesthetics on
cardiac output and organ conductance using the
quantitative data provided by Smith and Smith
(1972). We were well aware that its constants
originate from measurements in man and not in
dogs. We did not verify all the detailed data of the
model (blood flow to the brain, halothane
solubility in the organs, etc.). To tune our
halothane feedback system, the model was modified
by the serial addition of compartments for the real
and virtual volume of the anaesthetic breathing
system plus the addition of delay times between
these compartments. Our measured data of uptake
and concentration were compared with this
modified model by using the area between the
theoretical and measured curves and dividing it by
the total area under the theoretical curve. This
resulted in an agreement of 10.6 % for the inspired
and of 5.3% for the end-tidal concentration.
These figures could be improved considerably by
decreasing cardiac output and increasing pul-
monary shunt in the model. However, this
manipulation led to a smaller theoretical uptake
from the alveolar gas space, which in turn caused
a greater deviation between theoretical and
measured curves for arterial, cerebral venous and
mixed venous blood concentrations.
The arterial concentration was still only 78 % of
the end-tidal after the first 57 min of the 1 MAC
wash-in. Eger and Bahlman (1971) tried to predict
arterial concentration by using the difference
between inspired and end-tidal anaesthetic con-
centration. In human healthy volunteers, they
found that the end-tidal-arterial concentration
difference was always 17% of the inspired-end-
tidal concentration difference. However, the
correlation coefficient was only 0.60 and it was not
stated over which period these measurements were
performed. Applying this method to our results
gave a value of 16 % during the 1 MAC period and
a correlation coefficient of 0.64. During the 2 MAC
period, there was no correlation. We concluded
that this method of predicting arterial concentration
from end-tidal concentration was not valid.
The arterial to end-tidal concentration difference
may be predicted by modelling. The Zwart, Smith
and Beneken (1972) model allowed prediction of
the arterial concentration with 7% accuracy.
According to other authors, the end-tidal—arterial
gradient depends mainly on the right-to-left shunt
(Eger, 1964; Stoelting, 1972; Stoelting and
Longnecker, 1972), but during anaesthesia for
dogs this shunt is approximately only 11.2%
(Pavlin et al., 1980), which is too low to explain the
measured arterial-end-tidal difference. Deadspace
ventilation may also contribute. Pang and col-
leagues (1980) found that the persistence of an
end-tidal—arterial gradient resulted mainly from a
continuous transfer of halothane to the blood. The
transfer takes place to replenish losses attributable
to metabolism, diffusion through the skin and
prolonged absorption by adipose tissue.
Zwart, Smith and Beneken (1972) predicted a
rapid equilibration between arterial blood and
anaesthetic concentration in the brain. However,
in our dog study the cerebral venous concentration
was about 10% lower than the arterial even after
2 h. This can be explained by the admixture of
blood from slower compartments suggested by
Allott, Steward and Mapleson (1976), but a
persistent gradient of the magnitude we found,
could only be simulated in the model by allowing
an arbitrary 8 % admixture from fatty tissue to the
cerebral venous blood.
Models are not only helpful in the prediction of
cerebral tissue concentration from end-tidal
concentration, but can also improve dosage of
volatile anaesthetics. Cowles, Borgstedt and
Gillies (1972) found a mean difference of 11.4%
between actual and theoretical uptake for four
agents. Lowe and Ernst (1981) applied another
model and found that the uptake of any anaesthetic
gas was proportional to the alveolar gas concentra-
tion and cardiac output, and inversely proportional
to the square root of time. This model was
mathematically simpler than other models and
could be used easily to calculate dosage during
closed-loop clinical anaesthesia. When inserting
all measurable variables (blood-halothane concen-
tration, cardiac output) to the Lowe and Ernst
(1981) equation, the total area below the theoretical
curve was almost equal to that below the measured
uptake curve, although the shape of the curve was
different as the arterial concentration increased
only slowly, thereby delaying organ tissue uptake.
In clinical practice, the blood-halothane concen-
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tration and cardiac output are usually not continu-
ously available. Lowe and Ernst (1981) suggest
calculating cardiac output using either oxygen
consumption, which can be measured easily when
using a closed-loop system, or body weight and
calculating arterial concentration using alveolar
concentration and the blood/gas partition coeffic-
ient. However, when we inserted the measured
oxygen uptake values, together with a presumed
alveolar concentration and blood/gas partition
coefficient, to their equation, the uptake was
overestimated by 57.6%. When body weight was
used, it was overestimated by 24.8 %. Thus basing
dosage on oxygen uptake or body weight may
result in overdosage, but if the initial peak increase
had been used in place of the constant arterial
concentration, there would have been a better fit.
The Lowe and Ernst method only gives a rough
estimate of the whole body uptake of volatile
anaesthetics.
The results of the present study suggest that
control of the end-tidal anaesthetic concentration
together with the application of a multicompart-
ment uptake model allows for prediction of the
brain tissue anaesthetic concentration. This mode
of anaesthetic delivery may provide better oper-
ating conditions because of an established correla-
tion between brain tisue concentration and the
motor response (Wolfson et al., 1972). Halothane
anaesthesia delivered according to clinical signs is
reliable only after extensive clinical training.
According to Cullen and co-workers (1972), the
only clinical sign related to anaesthetic depth
during spontaneous ventilation is respiration, and
during controlled ventilation, arterial presure—but
only during the initial stage of anaesthesia.
The next step will certainly be to include the
model in the breathing system. A recent sophisti-
cated study (Chilcoat, Lunn and Mapleson, 1984)
was the first one to use a "feed forward loop" to
control brain concentration with Mapleson's
Model P (Mapleson, 1973). However, it is based
on on-line measurements of cardiac output and
arterial halothane which are difficult to perform in
clinical practice. Furthermore, it used an open
anaesthetic breathing system and did not verify
brain tissue concentration.
The variable which is on-line, which can be
measured non-invasively and which is the closest
alternative to brain concentration is the end-tidal
concentration. Future anaesthesia systems will,
therefore, most probably control brain concentra-
tion by adjusting end-tidal concentration according
BRITISH JOURNAL OF ANAESTHESIA
to a model which is included in the anaesthetic
breathing system.
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